Geode Capital Management LLC Buys 179,103 Shares of Senseonics Holdings, Inc. (NYSE:SENS)

Geode Capital Management LLC increased its stake in shares of Senseonics Holdings, Inc. (NYSE:SENS) by 3.2% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 5,838,396 shares of the company’s stock after acquiring an additional 179,103 shares during the period. Geode Capital Management LLC owned 0.99% of Senseonics worth $2,042,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. Symmetry Partners LLC bought a new stake in shares of Senseonics during the third quarter valued at approximately $164,000. Cubist Systematic Strategies LLC boosted its stake in Senseonics by 25.9% during the second quarter. Cubist Systematic Strategies LLC now owns 415,404 shares of the company’s stock worth $166,000 after buying an additional 85,501 shares in the last quarter. GSA Capital Partners LLP bought a new stake in Senseonics in the 3rd quarter valued at $117,000. Finally, FMR LLC raised its stake in shares of Senseonics by 48,267.2% in the 3rd quarter. FMR LLC now owns 168,318 shares of the company’s stock valued at $59,000 after buying an additional 167,970 shares in the last quarter. 12.36% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on SENS. StockNews.com started coverage on Senseonics in a research note on Thursday, December 26th. They issued a “sell” rating on the stock. HC Wainwright reiterated a “buy” rating and issued a $2.00 price target on shares of Senseonics in a research report on Friday, November 15th.

Insider Buying and Selling

In other news, CFO Frederick T. Sullivan bought 124,933 shares of the firm’s stock in a transaction that occurred on Thursday, December 12th. The stock was acquired at an average cost of $0.38 per share, with a total value of $47,474.54. Following the completion of the purchase, the chief financial officer now owns 2,478,844 shares of the company’s stock, valued at $941,960.72. This represents a 5.31 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Timothy T. Goodnow bought 315,000 shares of the company’s stock in a transaction dated Tuesday, December 10th. The stock was purchased at an average cost of $0.31 per share, for a total transaction of $97,650.00. Following the completion of the acquisition, the chief executive officer now owns 11,310,355 shares in the company, valued at $3,506,210.05. This trade represents a 2.86 % increase in their position. The disclosure for this purchase can be found here. 3.60% of the stock is currently owned by company insiders.

Senseonics Stock Performance

Shares of NYSE:SENS opened at $0.43 on Thursday. The firm’s 50 day simple moving average is $0.38 and its 200 day simple moving average is $0.38. Senseonics Holdings, Inc. has a fifty-two week low of $0.25 and a fifty-two week high of $0.75. The company has a market capitalization of $256.23 million, a price-to-earnings ratio of -3.31 and a beta of 0.64. The company has a debt-to-equity ratio of 59.17, a current ratio of 2.47 and a quick ratio of 2.38.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.